Published in Int J Pharm on August 22, 2008
PLA micro- and nano-particles. Adv Drug Deliv Rev (2016) 0.75
Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging. J Control Release (2017) 0.75
Bioactive polymeric scaffolds for tissue engineering. Bioact Mater (2016) 0.75
Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Control Release (2005) 2.17
Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm (2004) 1.30
Nerve conduits and growth factor delivery in peripheral nerve repair. J Peripher Nerv Syst (2007) 1.29
TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. Vaccine (2008) 1.26
Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev (2005) 1.22
Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems. J Control Release (2010) 1.20
Silk fibroin matrices for the controlled release of nerve growth factor (NGF). Biomaterials (2007) 1.17
Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro. Vaccine (2003) 1.14
Localized insulin-like growth factor I delivery to enhance new bone formation. Bone (2003) 1.12
Particulate vaccines: on the quest for optimal delivery and immune response. Drug Discov Today (2011) 1.10
Schwann cell delivery of neurotrophic factors for peripheral nerve regeneration. J Peripher Nerv Syst (2010) 1.07
Synergistic effect of GDNF and NGF on axonal branching and elongation in vitro. Neurosci Res (2009) 1.05
Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells. Vaccine (2005) 1.05
In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres. Eur J Pharm Sci (2002) 1.01
Growth factor delivery systems and repair strategies for damaged peripheral nerves. J Control Release (2011) 0.99
Collagen nerve conduits releasing the neurotrophic factors GDNF and NGF. J Control Release (2009) 0.98
Lympho-geographical concepts in vaccine delivery. J Control Release (2010) 0.97
Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response. J Drug Target (2009) 0.97
Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in mice. J Antimicrob Chemother (2005) 0.92
Delivery of tumor antigens to dendritic cells using biodegradable microspheres. Methods Mol Med (2005) 0.89
Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability. Int J Pharm (2010) 0.89
Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy. J Immunol Methods (2004) 0.88
Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes. J Antimicrob Chemother (2004) 0.88
Effect of controlled co-delivery of synergistic neurotrophic factors on early nerve regeneration in rats. Biomaterials (2010) 0.87
Controlled nerve growth factor release from multi-ply alginate/chitosan-based nerve conduits. Eur J Pharm Biopharm (2008) 0.86
Surface coating of PLGA microparticles with protamine enhances their immunological performance through facilitated phagocytosis. J Control Release (2008) 0.86
Ultrasonic atomisation into reduced pressure atmosphere--envisaging aseptic spray-drying for microencapsulation. J Control Release (2004) 0.86
One-step preparation of polyelectrolyte-coated PLGA microparticles and their functionalization with model ligands. J Control Release (2005) 0.85
Continuous contact- and contamination-free ultrasonic emulsification-a useful tool for pharmaceutical development and production. Ultrason Sonochem (2004) 0.85
The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles. Biomaterials (2006) 0.85
Variations in glial cell line-derived neurotrophic factor release from biodegradable nerve conduits modify the rate of functional motor recovery after rat primary nerve repairs. Eur J Neurosci (2007) 0.84
In vivo uptake of an experimental microencapsulated diphtheria vaccine following sub-cutaneous immunisation. Vaccine (2004) 0.83
A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles. Pharm Res (2007) 0.82
Biodegradable microspheres alone do not stimulate murine macrophages in vitro, but prolong antigen presentation by macrophages in vitro and stimulate a solid immune response in mice. J Control Release (2005) 0.82
Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres. J Control Release (2004) 0.82
Insulin-like growth factor I-releasing alginate-tricalciumphosphate composites for bone regeneration. Pharm Res (2005) 0.81
Development of synthetic biodegradable microparticulate vaccines: a roller coaster story. Expert Rev Vaccines (2007) 0.81
Encapsulation of antigen in poly(D,L-lactide-co-glycolide) microspheres protects from harmful effects of γ-irradiation as assessed in mice. Eur J Pharm Biopharm (2011) 0.81
An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria. J Pharm Sci (2003) 0.80
Hydrogel nerve conduits produced from alginate/chitosan complexes. J Biomed Mater Res A (2007) 0.80
On technological and immunological benefits of multivalent single-injection microsphere vaccines. Pharm Res (2002) 0.80
Tumor eradication by immunotherapy with biodegradable PLGA microspheres--an alternative to incomplete Freund's adjuvant. Int J Cancer (2011) 0.79
Formulation and drying of miconazole and itraconazole nanosuspensions. Int J Pharm (2013) 0.79
Childhood and malaria vaccines combined in biodegradable microspheres produce immunity with synergistic interactions. J Control Release (2004) 0.78
Nerve conduit scaffolds for discrete delivery of two neurotrophic factors. Eur J Pharm Biopharm (2013) 0.77
Impact of IGF-I release kinetics on bone healing: a preliminary study in sheep. Eur J Pharm Biopharm (2013) 0.77
Effect of oil-in-water emulsions on 5-aminolevulinic acid uptake and metabolism to PpIX in cultured MCF-7 cells. Pharm Res (2004) 0.76
Flow-through ultrasonic emulsification combined with static micromixing for aseptic production of microspheres by solvent extraction. Eur J Pharm Biopharm (2005) 0.76
Polyelectrolyte LbL microcapsules versus PLGA microparticles for immunization with a protein antigen. J Control Release (2011) 0.76
Simultaneous quantification of polymeric and surface active stabilizers of nanosuspensions by using near-infrared spectroscopy. Drug Dev Ind Pharm (2012) 0.75
Development of a novel casein-protamine based microparticles for early feeding of fish larvae: in vitro evaluation. J Microencapsul (2007) 0.75
Foreword - In honor of Prof. em. Dr. Hans Peter Merkle on the occasion of his 70th birthday. Eur J Pharm Biopharm (2013) 0.75
Preventing restenosis in early drug-eluting stent era: recent developments and future perspectives. J Pharm Pharmacol (2004) 0.75